IT
Healthcare & Life Sciences
Intrinsic Therapeutics
Intrinsic Therapeutics is a Healthcare & Life Sciences startup, most recent round Series C+, 2 tracked investors.
series-c-plus
series-c-plus
Stage
2
Investors
About Intrinsic Therapeutics
Intrinsic Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Intrinsic Therapeutics develops an implant designed to reduce the risk of recurrence following discectomy surgery in patients treated for disc herniations.
Explore Intrinsic Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.